Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

MHRA approves world's first lower-carbon beclometasone inhalers

The Medicines and Healthcare products Regulatory Agency (MHRA) has granted approval for beclometasone dipropionate inhalers for long‑term asthma management in adults and children.

iStock
Trump's generic drugs tariff threat: Sandoz to engage with US policymakers

US President Donald Trump has said that generic drugmakers will have to manufacture medicines for the US locally or be hit with a 100% tariff from August 2028.

iStock
MHRA issues defect alert for ADHD drug Xaggitin XL

The Medicines and Healthcare Products Regulatory Agency (MHRA) has issued a Class 4 medicines defect notification for Xaggitin XL Prolonged-release tablets.

NHS Bedfordshire and Luton CYP services